Vela Diagnostics In Brief This Week: Cue Health, Qiagen, Co-Diagnostics, Vela Diagnostics, Thermo Fisher, HTG, More News items for the week of Jan. 3, 2022. Vela Diagnostics, National Cancer Center of Singapore to Develop CDx for EGFR-TKI Therapies Vela Diagnostics and NCCS will evaluate the efficacy of the assay in a clinical trial to test the response of patients to EGFR-TKI therapies. Vela Diagnostics Receives Second FDA Emergency Use Authorization for SARS-CoV-2 Molecular Test The second EUA for a test that targets the ORF1a and N genes is for an automated version of a manual test that had been granted EUA in August. Vela Diagnostics, Capstone Healthcare Get FDA Emergency Use Authorization for Coronavirus Tests The Vela and Capstone tests are both PCR-based and designed to detect their viral RNA targets in nasopharyngeal and oropharyngeal swab specimens. Vela Diagnostics Automated Coronavirus Test Gets CE-IVD Mark Vela Diagnostics said that the RT-PCR-based test has also received provisional authorization from the Health Sciences Authority in Singapore. Apr 24, 2020 Vela Diagnostics, JN Medsys Get CE-IVD Marks for Coronavirus Tests Apr 20, 2020 Vela Diagnostics Awarded BARDA Funding for COVID-19 Test Apr 16, 2020 Vela Diagnostics Coronavirus RT-PCR Test Provisionally Authorized by Singapore Regulator Feb 7, 2020 In Brief This Week: LineaRx, OncoCyte, Vela Diagnostics, CosmosID, More Nov 5, 2019 FDA Authorizes Marketing of Vela Diagnostics NGS-Based HIV-1 Drug Resistance Mutation Test Mar 26, 2019 Vela Diagnostics Submits NGS HIV Genotyping, Drug Resistance Assay to FDA Jul 23, 2018 Vela Diagnostics Accelerates Entry Into US Microbiology Market With Great Basin Buy Premium Jun 25, 2018 Vela Diagnostics Buys Great Basin Scientific Aug 18, 2017 Great Basin in Default of Senior Notes for $18.3M Jul 13, 2017 Great Basin Receives FDA Clearance for Stool Bacterial Pathogens Panel Jun 22, 2017 Great Basin Closes $2.1M Offering Jun 20, 2017 Great Basin Scientific Prices $2.7M Securities Offering May 23, 2017 Great Basin Plans to Raise $3.5M May 22, 2017 Great Basin Reports 14 Percent Revenue Growth in Q1 May 16, 2017 Great Basin Whooping Cough Test Gets CE Marking May 12, 2017 In Brief This Week: Alere, Fulgent Diagnostics, Trovagene, Great Basin, and More Apr 12, 2017 Great Basin Gets CE Mark for Stool Pathogens Panel Apr 10, 2017 Great Basin Restructures Convertible Securities, Gaining Access to Cash Apr 3, 2017 Great Basin Whooping Cough MDx Clears FDA Mar 22, 2017 Great Basin Q4 Revenues Rise 39 Percent Load More Breaking News Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution Thermo Fisher, Oncocyte Ink Development, Comarketing Deal for Cancer IVDs Yourgene Health Enters Three-Year £5M Term Loan Facility The Scan And a Fourth? A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times. For Better Science Software A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports. Recommendation Explanations The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information. Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.